Genentech will be granted an exclusive license to develop and commercialize the degrader worldwide, and will be fully responsible for the development and commercialization costs.
GlobalData’s ‘Pharmaceutical Intelligence Center’ observes that India is still in the nascent stage of developing these potential therapies as currently only four cell/gene therapy molecules are being developed in the country.
Profit after Tax stood at Rs. 105 crore as compared to Rs. 119 crore on account of higher treasury income in Q1 FY22, non-cash ESOP cost, depreciation on account of acquired brands and finance costs in Q1 FY23
Biopharma and CROs to benefit from simplified access to global research sites
George Svokos joins Avet after serving as a strategic business advisor to numerous global healthcare companies
Cellutions BioStorage is a comprehensive biomaterial storage and logistics company with a vision to leverage advanced technologies to serve biopharmaceutical companies
Supports development and commercialization of complex oral drugs using sensitive molecules, including biologicals
EVERSANA and Compai Pharma will provide medical and commercial resources to healthcare partners
Company is investing more than €100 million in the expansion of the Halle site
Pfizer aims to achieve net-zero targets ten years earlier than the expectations of the Net-Zero Standard
Subscribe To Our Newsletter & Stay Updated
